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Abstract. We have employed a recombinant plasmid, 
pBHIVl, carrying the long terminal repeat (LTR) of the 
human immunodeficiency virus-1 (HIV-1) linked to the repor­
ter chloramphenicol acetyl transferase (cat) gene and to the 
aminoglycoside phosphotransferase (aph) gene as a selectable 
marker. We have introduced pBHIVl in rat 208F and human 
MRCSV40TGR fibroblasts and obtained stable geneticin resis­
tant RFBHIV1-1 and SVTGHIV-1 transfectant cells respec­
tively. Both RFBHIV1-1 and SVTGHIV1-1 cells express CAT 
activity from the HTV LTR promoter. The response to insulin, 
epidermal growth factor, hydrocortisone and dexamethasone 
was studied on the LTR regulated CAT activity in both cell 
lines. It was found that, at optimal concentrations, insulin, 
epidermal growth factor and hydrocortisone regulate positively 
the expression of CAT from the HTV LTR in rat RFBHIV1-1 
but not in human SVTGHIV1-1 cells. On the other hand 
dexamethasone at 10~5M stimulated CAT activity in both types 
of cells. 
Human immunodeficiency viruses are the cause of acquired 
immune deficiency syndrome (AIDS) (1,2). These viruses 
infect and destroy the T4 lymphocytes and establish chronic 
infections (3). Understanding the regulation of HIV gene 
expression is of paramount importance in order to prevent 
and eventually cure AIDS. The HIV LTR is a complex 
modular structure of protein binding sites through which 
cellular factors can regulate gene expression. Stimuli which 
are known to affect HIV LTR activity include several 
mitogens i.e. phytohemaglutinin (4, 5), phorbol esters (6, 8), 
ionomycin (4) and gene products i.e. tat (9, 10), or ras p21 
(11). " 
The demonstration that several hormones enhance the 
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production of HIV by mononuclear leukocytes infected in 
vitro and that hydrocortisone in particular facilitates the 
isolation of virus from peripheral blood mononuclear cells 
established in cell culture from AIDS patients (12) prompted 
us to examine further whether hormones and growth factors 
act through the virus LTR sequences. We find that both types 
of regulators can augment gene expression from the HIV 
LTR sequences in an in vitro system. 
Materials and Methods 
Recombinant plasmids and cell lines. Plasmid pBHIVl carrying a 728 bp 
Xhol-HindlII DNA fragment containing the HIV-1 LTR sequences was 
constructed by inserting a 1.9 Kb BamHI fragment carrying the aph gene 
into the single BamHI site of plasmid pBC12 | HIV | CAT (13). Plasmid 
pBC12 | HIV [ CAT was obtained from B.R. Cullen (13). 
The spontaneously immortalized rat 208F and the SV40 immortalized 
human MRCSV40TGR fibroblasts were used as recipients to obtain the 
RFBHIV1-1 and SVTGHIV1-1 stable geneticin resistant transfectant cell 
lines with plasmid pBHIVl (14). DNA transfections were carried out 
using the calcium phosphate technique (15) as modified (16). 
Treatment of cells and CA Τ assays. Cells were plated at 1.5 X 106 / 75cm2 
flask in Ham's SF12 medium containing 10% FCS at 37° C. 24h later the 
medium was replaced with Ham's SF12 medium containing 0.5% FCS and 
left for another 24h at 37°C. Then the medium was changed with Ham's 
SF12 containing 0.5% FCS and the various concentrations of growth 
factor or hormone. Cells were harvested 24h later and tested for CAT 
activity as previously described.(17). 
Results 
Effects of insulin and epidermal growth factor (EGF) on the 
HIV LTR. It has been shown previously that the HIV LTR 
contains the primary c«-acting regulatory sequences of the 
virus. It was therefore of interest to examine the effect of the 
growth factors and hormones on the transcriptional regula­
tion of HIV LTR. Stable transfectants expressing the CAT 
gene driven by the HIV LTR were obtained. The effect of 
insulin on the LTR was tested as described in Materials and 
Methods. Autoradiographs of representative chromatograms 
from CAT assays are shown in Figure 1 for rat cells and in 
Figure 2 for human fibroblasts. The corresponding histo­
grams representing the increase in CAT activity are shown in 
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Figure 1. Chromatogram of representative CAT assays with extracts from recipient and transfectant RFBH1V1-I cells with and without treatment with 
insulin, HDC or DEX. 
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Figure 2. Chromatogram of representative CAT assays with extracts from recipient and SVTGHIVI-I cells with and without treatment with insulin or 
EGF. 
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Figure 3. Induction cf CAT activity by insulin. RFBHIV1-1 and 
SVTGHIV1-1 cells were plated at 1.5x10^175 cm2 flask in Ham's SF12 
medium containing 10% FCS at 37° C. 24 h later the medium was replaced 
with Ham's SF12 medium containing 0.5% FCS and left for another 24 h at 
37°C. Then the medium was changed with Ham's SF12 containing 1% FCS 
and the various concentrations of insulin. Cells were harvested 24h later 
and tested for CA Τ activity as described in Materials and Methods. Relative 
values of CA Τ activity in RFBH1V1-1 and SVTGHIVI-1 cells were 13 and 
29 pmole acetylated chloramphenicol Ipg protein per hour incubation, 
respectively. Average from three experiments is given. Standard deviation 
was less than 10% of average values. 
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Figure 4. Chromatogram of representative CAT assays with extracts from 
recipient and transfectant RFBH1V1-1 cells with and without treatment with 
EGF. 
Figure 3. Whereas at l-10(^g insulin/ml, a 4 to 5-fold 
stimulation of CAT activity was found in rat cells, in human 
cells insulin did not alter CAT activity from HIV LTR. 
The effect of EGF on HIV LTR was also tested. Similarly, 
CAT assays are shown in Figure 4 for the rat and Figure 2 for 
human fibroblasts. The corresponding histograms represent­
ing the increase in CAT activity are shown in Figure 5. 
Whereas at 0.1-100 ng/ml EGF a 2.3 to 3.8-fold increase in 
CAT activity was found in rat cells, EGF had no effect on the 
human cells. 
The effect of hydrocortisone (HDC) and dexamethasone 
(DEX) on the HIV LTR. The effect of HDC was tested at 
concentrations varying from lXlO"5 to lXlO"6 M. Repre­
sentative chromatograms from CAT assays are shown in 
Figure 1 and Figure 6 for rat and human cells respectively. 
The corresponding histograms representing the increase in 
CAT activity are shown in Figure 7. Whereas at lxlO"6 to 
1X10"5M HDC a 1.9 to 2.8-fold increase in CAT activity was 
found in rat cells, in human cells HDC has no effect. 
The effect of DEX was also tested. At 10"5 M DEX a 
3.6-fold increase in CAT activity was observed in rat (Figure 
1 and 8) and a 2.4-fold increase in human (Figures 6 and 7) 
cells, respectively. 
Discussion 
Several regulatory elements have been described on the 
HIV-1 LTR. Among them are included a trans-acting respon-
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Figure 5. Induction of CA Τ activity by EGF. CA Τ values were obtained as 
described in Figure 3. 
sive element (9, 10), an enhancer region including binding 
sites for NF-kB and Spi transcripsion factors (18, 19), a 
phorbol ester inducible element (5) and a negative regulatory 
element (10). 
Glucocorticosteroids are known to have a wide range of 
effects including the modulation of expression of some cellu­
lar genes (20-24). 
Previous studies have suggested a role for corticosteroids 
and possible gonadal steroids in the modulation of virus 
expression and/or release and have suggested that the capac­
ity of these and other compounds to induce virus replication 
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Figure 6. Chromatogram of representative CAT assay with extracts from recipient and SVTGHIV1-1 cells with and without treatment with HDC or DEX. 
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Figure 7. Induction of CAT activity by HDC. CATvalues were obtained as 
described in Figure 3. 
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Figure 8. Induction of CA Τ activity by DEX. CA Τ values 
described in Figure 3. 
were obtained as 
should be considered prior to their possible clinical use (12). 
In the present study we have investigated the effect of 
growth factors, i.e. insulin and EGF, and hormones, i.e. 
HDC and DEX, on the transcriptional activity of HIV LTR. 
We found that the response was cell-type dependent 
Although in rat fibroblasts the HIV LTR responded strongly 
to all the above factors, in human fibroblasts the LTR 
responded only to DEX. 
The mechanism of action of these various factors on the 
HIV LTR is yet unknown. However, it may be postulated 
that they operate through the modification of DNA binding 
proteins which interact with the HIV LTR. 
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